Regulatory Approval vs Guideline Endorsement of Novel BP-Lowering Treatments

This Viewpoint describes the benefits and barriers of conducting cardiovascular disease outcome trials to provide evidence of effectiveness of novel blood pressure (BP)–lowering therapies in reducing hypertension.